Skip to content Skip to navigation

CVS Algal-900 DHA Supplement Settlement

Share
Active: 
Open
Settlement Structure: 
Case Summary: 

CVS is settling a class action over its Algal-900 DHA supplement containing docosahexaenoic acid algal oil. The complaint alleged that the product was misrepresented as being “clinically shown to improve memory” or creating “clinically shown memory improvement” on its label or package. 

Docket Number: 
2:16-cv-0200498
Company: 
CVS
Class Period: 
Saturday, November 15, 2008 to Friday, September 30, 2016
Filing Deadline: 
Thursday, December 12, 2019
Objection Deadline: 
Friday, September 13, 2019
Exclusion Deadline: 
Friday, September 13, 2019
Final Approval Hearing: 
Thursday, September 26, 2019
CVS Algal-900 DHA